According to the Polish media outlet Rynekzdrowia.pl on April 23, Wojciech Konieczny, the Deputy Minister of Health in Poland, recently stated on a radio program that the number of prescriptions for medical marijuana is experiencing a "snowballing" growth, and the department has implemented controls on these prescriptions in advance.
Koneczny revealed that the Department of Health wants to know if anyone is misusing medical marijuana prescriptions for recreational purposes. The specific number of prescriptions issued is now known. "It's a much larger number than we anticipated," he added, suggesting that the Department of Health may have underestimated the number of patients who would use medical marijuana.
If medical marijuana is used correctly, it can be a very effective medication that has already brought relief to many patients. We may need to consider importing more marijuana... Our analysis is moving in that direction, potentially increasing regulations, but currently, there may not be a need for that based on current sales figures.
Konezny also discussed the efforts to amend regulations limiting the sale of e-cigarettes. On one hand, they will focus on implementing the directive concerning tobacco products (specifically the 2022 EU Directive on innovative tobacco heating products). On the other hand, the department is considering banning disposable e-cigarettes.
We hope that these regulations come into effect simultaneously... I hope that the ban will take effect starting from early next year.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
